The gray market for peptides, those injectable compounds promising weight loss, muscle gain, and anti-aging benefits, is booming. And it’s running on crypto.
A Chainalysis report released on June 4, 2026, found that inflows to identified peptide vendors surged from $12 million in Q4 2025 to $32 million in Q1 2026. That’s a 159% increase in a single quarter. Current Q2 pacing suggests inflows could reach $39 million, putting the market on an annualized run rate exceeding $100 million.
From fentanyl to GLP-1 analogs
The viral “looksmaxxing” subculture on TikTok has driven demand for off-label analogs of GLP-1 receptor agonists, the same class of drugs behind Ozempic and Wegovy, with users sharing protocols for stacking various peptides, from weight-loss compounds to growth-hormone secretagogues, often with zero medical supervision.
Chainalysis tracked certain Chinese chemical manufacturers who pivoted from selling fentanyl precursors and amphetamines to direct-to-consumer peptide sales. One example cited in the report: Shanghai Sigma Audley transitioned from fentanyl-precursor sales to peptides using the same contact details and wallets.
